Ersilia Bifulcos bilde

Ersilia Bifulco

  • E-postErsilia.Bifulco@uib.no
  • Telefon+47 55 58 53 53
  • Besøksadresse
    Thormøhlens gate 53 A/B
    5006 Bergen
  • Postadresse
    Postboks 7803
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2023). Progressive Motor and Non-Motor Symptoms in Park7 Knockout Zebrafish. International Journal of Molecular Sciences.
  • Vis forfatter(e) (2023). Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity. Journal of Structural Biology. 10 sider.
  • Vis forfatter(e) (2022). Steroidogenic factor 1 (NR5A1) induces multiple transcriptional changes during differentiation of human gonadal-like cells. Differentiation. 83-100.
  • Vis forfatter(e) (2022). Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency. Hormone and Metabolic Research. 471-478.
  • Vis forfatter(e) (2021). Ultraviolet radiation as a predictor of sex hormone levels in postmenopausal women: A European multi-center study (ECRHS). Maturitas. 49-55.
  • Vis forfatter(e) (2021). Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial. NPJ breast cancer. 1-34.
  • Vis forfatter(e) (2020). Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Molecular Oncology. 11 sider.
  • Vis forfatter(e) (2020). First-in-human pharmacokinetics of tamoxifen and its metabolites in the milk of a lactating mother: A case study. ESMO Open. 1-5.
  • Vis forfatter(e) (2019). Exogenous female sex steroids may reduce lung ageing after menopause: A 20-year follow-up study of a general population sample (ECRHS). Maturitas. 29-34.
  • Vis forfatter(e) (2019). Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database. Breast Cancer Research and Treatment. 185-195.
  • Vis forfatter(e) (2019). Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. British Journal of Cancer. 545-555.
  • Vis forfatter(e) (2018). Temporomandibular Disorders Related to Stress and HPA-Axis Regulation. Pain Research and Management.
  • Vis forfatter(e) (2017). Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. Breast Cancer Research.
  • Vis forfatter(e) (2016). Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study. Journal of Allergy and Clinical Immunology. 50-57.e6.
  • Vis forfatter(e) (2015). Response of cortisol metabolites in the insulin tolerance test and synacthen tests. Physiological Research. S237-S246.
  • Vis forfatter(e) (2013). Antioxidant capacity and vasodilatory properties of Mediterranean food: The case of Cannonau wine, myrtle berries liqueur and strawberry-tree honey. Food Chemistry. 686-691.
  • Vis forfatter(e) (2020). Relationship between CYP2D6 genotype, tamoxifen metabolites, and adverse events, tumor biomarkers and breast cancer recurrence in a low-dose phase III trial in noninvasive disease. Journal of Clinical Oncology.

Se fullstendig oversikt over publikasjoner i CRIStin.